tiprankstipranks
Mosaic ImmunoEngineering (CPMV)
OTHER OTC:CPMV
US Market
Holding CPMV?
Track your performance easily

Mosaic ImmunoEngineering (CPMV) Income Statement

26 Followers

Mosaic ImmunoEngineering Income Statement

Last quarter (Q ), Mosaic ImmunoEngineering's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Mosaic ImmunoEngineering's net income was $-186.73K. See Mosaic ImmunoEngineering’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20May 20
Total Revenue
----$ 0.00-
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 503.84K$ 1.40M$ 2.63M$ 3.50M$ 835.63K$ 511.00
Operating Income
$ -1.04M$ -1.40M$ -2.63M$ -3.50M$ -835.63K$ -511.00
Net Non Operating Interest Income Expense
$ -2.80K$ 3.41K$ 151.55K$ 36.00$ 91.00$ 12.07K
Other Income Expense
$ -16.65K$ -30.86K$ 400.60K$ 150.83K$ -5.10K$ 74.98K
Pretax Income
$ -1.10M$ -1.01M$ -2.38M$ -3.68M$ -840.64K$ -511.00
Tax Provision
-$ 2.40K$ 2.40K$ 2.40K$ 1.60K$ 1.60K
Earnings From Equity Interest Net Of Tax
-----$ -74.98K
Net Income Common Stockholders
$ -1.10M$ -1.01M$ -2.38M$ -3.68M$ -842.24K$ -1.06M
Basic EPS
$ -0.16$ -0.14$ -0.33$ -0.55$ -1.05-
Diluted EPS
$ -0.16$ -0.14$ -0.33$ -0.55$ -1.05-
Basic Average Shares
$ 28.95M$ 7.24M$ 7.24M$ 6.71M$ 805.80K$ 398.55M
Diluted Average Shares
$ 28.95M$ 7.24M$ 7.24M-$ 805.80K$ 398.55M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 503.84K$ 1.40M$ 2.63M$ 3.50M$ 835.63K$ 511.00
Net Income From Continuing And Discontinued Operation
$ -1.10M$ -1.01M$ -2.38M$ -3.68M$ -842.24K$ -1.06M
Normalized Income
$ -437.74K---$ -842.24K-
Interest Expense
----$ 0.00-
EBIT
$ -540.45K$ -1.44M$ -2.23M$ -3.52M$ -840.64K$ -996.02K
EBITDA
$ -540.45K$ -1.44M$ -2.23M$ -3.52M$ -840.64K$ -995.53K
Currency in USD

Mosaic ImmunoEngineering Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis